Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin
- 1 May 1997
- journal article
- clinical trial
- Published by Elsevier in Leukemia Research
- Vol. 21 (5) , 415-425
- https://doi.org/10.1016/s0145-2126(96)00110-5
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Apoptosis in myelodysplasia: A paradox or paradigmLeukemia Research, 1995
- Advances and controversies in the study of programmed cell death/apoptosis in the development of and therapy for cancerCurrent Opinion in Oncology, 1994
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992
- The Origins of DNA Breaks: A Consequence of DNA Damage, DNA Repair, or Apoptosis?Cancer Investigation, 1992
- Ineffective hemopoiesis in the myelodysplastic syndromes (MDS) as studied by daily in situ observation of colony‐cluster formationThe International Journal of Cell Cloning, 1991
- Apoptosis is a Common Histopathological Finding in Myelodysplasia: the Correlate of Ineffective HaematopoiesisLeukemia & Lymphoma, 1990
- Mechanisms and prognostic value of cell kinetics in the myelodysplastic syndromesBritish Journal of Haematology, 1987
- The myelodysplastic syndrome: analysis of laboratory characteristics in relation to the FAB classificationBritish Journal of Haematology, 1985
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982
- Ferrokinetics and Erythropoiesis in Man: The Measurement of Effective Erythropoiesis, Ineffective Erythropoiesis and Red Cell Lifespan using 59FeBritish Journal of Haematology, 1975